跳至主要内容
临床试验/EUCTR2005-004599-19-GB
EUCTR2005-004599-19-GB进行中(未招募)1 期

International Collaborative Treatment Protocol for the Infants Under One Year with Acute Lymphoblastic or Biphenotypic Leukemia - INTERFANT 06

niversity of Birmingham0 个研究点目标入组 500 人开始时间: 2008年1月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children aged 365 days or less with newly diagnosed acute lymphoblastic leukemia (ALL) or biphenotypic leukemia according to EGIL criteria. Children with CNS or testicular leukemia at diagnosis are eligible.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 75
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients are excluded from the study if at least one of the following exclusion criteria applies:
  • Mature B-ALL, defined by the immunophenotypical presence of surface immunoglobulines or t(8;14) and breakpoint as in B-ALL.
  • The presence of the t(9;22) (q34;q11) or bcr-abl fusion in the leukemic cells (if these data are not known, the patient is eligible).
  • Age > 365 days.
  • Relapsed ALL.
  • Systemic use of corticosteroids less than 4 weeks before diagnosis. Patients who received corticosteroids by aerosol are eligible for the study.

研究者

相似试验